2023;72(Suppl 1):127-OR
Quando tirzepatide ha mostrato perdite di peso del 20-22% nei trial SURMOUNT, il vantaggio rispetto al semaglutide 2,4 mg (allora fermo al 15-16%) era netto e clinicamente rilevante
Agents like Setmelanotide or GLP-1 RAs may be integrated alongside nutritional, behavioral, and endocrine support to optimize clinical outcomes (Figs
There are many drivers of this growth, including: The appeal of increased drug efficacy Improved side effect profile Greater obesity and diabetes prevalence Additional indications (e.g., heart, kidney, and liver health) Social media Cultural shifts toward greater acceptance of obesity as a disease Over 12% of the U.S
Website External link for Shed Industry Health and Human Services Company size 51-200 employees Headquarters Salt Lake City, Utah Type Privately Held Founded 2022 Specialties Telehealth, Weight Loss, Semaglutide, Tirzepatide, Holistic Health, Health Coaching, Health Coach, and Healthcare Locations Primary Get directions Salt Lake City, Utah, US Employees at Shed Updates We're excited to expand Shed's catalogue of products with a new suite of prescription sexual health treatments designed to help people address some of the most commonbut least talked abouthealth concerns